Guidelines For Clinical Practice
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 14, 2012; 18(46): 6782-6789
Published online Dec 14, 2012. doi: 10.3748/wjg.v18.i46.6782
Table 2 The use of faecal calprotectin to predict relapse
AuthorPatient populationCut-off calprotectin levelSensitivity for relapse (%)Specificity for relapse (%)Increased risk of relapse
Costa et al[21]UC150 μ/L898214 fold
CD87432 fold
D'Incà et al[29]UC130 mg/kg70702.4 fold
CD65621.7 fold
García-Sánchez et al[30]CD + UC120 μ/g8060
Ileal CD223 μ/g8350
Tibble et al[49]CD + UC50 mg/L (250 μ/g)9083
Laharie et al[50]CD post IFX130 μ/g6148
250 μ/g4357
Kallel et al[70]Colonic CD340 μ/g8090.718.8 fold
Gisbert et al[71]CD + UC150 μ/g6969